Bill
Bill > A3692
NJ A3692
NJ A3692Requires physicians and other prescribers to obtain electronic or written consent for certain medications with "black box warnings."
summary
Introduced
02/12/2024
02/12/2024
In Committee
02/12/2024
02/12/2024
Crossed Over
Passed
Dead
01/12/2026
01/12/2026
Introduced Session
2024-2025 Regular Session
Bill Summary
This bill requires physicians, physician assistants, advanced practice nurses, and other authorized prescribers to obtain informed electronic or written consent prior to prescribing them psychotropic medications that are accompanied by a "black box warning," which consent is to include an electronic or a written acknowledgement that the patient or the patient's guardian received notification about the black box warning. The bill specifies that in cases where electronic or written consent cannot be obtained but oral consent is provided, the prescriber must make a notation in the patient's file indicating the date and circumstances of the informed consent. The United States Food and Drug Administration (FDA) requires pharmaceutical companies to place a "black box warning" on a drug label if medical studies indicate that the drug carries a significant risk of serious or life-threatening adverse effects. A "black box warning" is the strongest warning that the FDA requires. A physician, physician assistant, advanced practice nurse, or other authorized prescriber who violates the requirements established under the bill is subject to disciplinary action by the applicable State professional licensing board.
AI Summary
This bill requires physicians, physician assistants, advanced practice nurses, and other authorized prescribers to obtain informed electronic or written consent prior to prescribing psychotropic medications that have a "black box warning" from the United States Food and Drug Administration (FDA). A "black box warning" is the strongest warning the FDA requires on a drug label when medical studies indicate the drug carries significant risks of serious or life-threatening adverse effects. The bill specifies that if electronic or written consent cannot be obtained but oral consent is provided, the prescriber must make a note in the patient's file. Prescribers who violate the requirements of this bill are subject to disciplinary action by their state professional licensing board.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Introduced, Referred to Assembly Health Committee (on 02/12/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2024/A3692 |
| BillText | https://pub.njleg.gov/Bills/2024/A4000/3692_I1.HTM |
Loading...